HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Gregory Abel, MD, MPH

Hematologist Oncologist, Director, Older Adult Hematologic Malignancy Program, Associate Professor of Medicine, Harvard Medical School

15 years treating AML

Clinical Expertise

Dr. Abel's research aims to apply health services methods to understand the experiences of patients with cancer and to answer questions about the effectiveness of cancer care. He is also interested in evaluating how intensive cancer therapy affects outcomes other than survival, such as quality of life and financial well-being. He primarily focuses on the hematologic malignancies, studying the impact of these diseases and their treatment from diagnosis to the end of life.

Location

Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
AbbVie
Amgen
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube